0 followers
User was viewed 4503 times (total).
Theodore J. Gillman
Theodore J Gillman, CFA, is a Managing Principal at Crito Capital. Ted has worked as an investment analyst, portfolio manager, and a product and sales manager. Before founding Crito, Ted was affiliated with Ariane Capital Partners LLC, a registered broker/dealer. Prior to Ariane, Ted was Director of Business Development with The Rohatyn Group, an investment adviser focused on emerging markets. At Rohatyn, he served in a number of capacities including US institutional distribution and private equity product management. Prior to Rohatyn, he worked at Davis Advisors, and what is now Gleacher & Co. Prior to Gleacher, he held senior positions at Lazard Asset Management in New York and London. Ted began his career in the securities industry at Wilkinson, O’Grady& Co., as an investment analyst. He earned an undergraduate degree from Tufts University and an MBA from The University of Virginia’s Darden School of Business Administration. He is a Chartered Financial Analyst.
Securities Disclaimer
This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.